Dear colleagues, You’ve heard me say it before, but you’ll hear it again: progress in malignant hematology is unprecedented, and myeloproliferative neoplasms (MPNs) as a…

Dear colleagues, This past weekend, top US hematologists gathered in Chicago at our first annual HemOnc Pulse Live meeting. The sessions were superb and addressed…

Dear colleagues, In cancer trials, it’s all about the endpoints; it’s essential to ensure that studies have endpoints that matter to patients. I was intrigued…

Dear colleagues, So much is happening in the world of myelodysplastic syndromes (MDS), and last week at the first annual HemOnc Pulse Live Meeting in…

Dear colleagues, I am thrilled to kick off the first annual HemOnc Pulse Live Meeting in Chicago, where we focus on “Unanswered Questions” in most…

Dear colleagues, We’re only a few days away from the inaugural #HOPLive24 meeting, where amazing faculty from around the world will gather in Chicago to…

Dear colleagues, We hear a lot about artificial intelligence (AI) and what it can do to help patients, clinical trials, and everyone in the health…

Dear Colleagues, I love reading, and today I want to share a few medical books and stories as we head into spring break. First, I…

Dear Colleagues, At the risk of sounding old, I am humbled every day by reminders of cancer care advancements and how these help our patients.…